In vitro findings using neuroblastoma and ex vivo synaptosomes demonstrated increased Tau-phosphorylation (Ser-202, Thr-181, and Thr-231) following Aβ peptide binding to α7 nAChR, which thereby represents a receptor potentially involved in amyloid induced Tau-pathology. The gene discussed is MAPT; the disease is neuroblastoma.